Pharma companies in the U.S. are working with the FDA to add mobile health tools to clinical trials, but it’s a complex path forward. In Europe, companies have to navigate not one market but several, which means working with several different regulatory bodies and cultures.

from Forbes – Tech http://ift.tt/1mfXvZk
via IFTTT